Cumulative update on pregnancy outcomes after fingolimod treatment in patients with multiple sclerosis

被引：0

作者：

Prach, L. M. ^{[1
]}

Moore, A. ^{[1
]}

Rezaallah, B. ^{[1
]}

Mcbride, G. ^{[1
]}

Khan, I. A. ^{[2
]}

Guennec, M. ^{[3
]}

Bhatt, A. ^{[2
]}

Geissbuehler, Y. ^{[1
]}

Leon, S. Lopez ^{[4
]}

Vukusic, S. ^{[5
]}

Butzkueven, H. ^{[6
]}

Tilson, H. ^{[7
]}

Macdonald, T. M. ^{[8
]}

Hellwig, K. ^{[9
]}

机构：

[1] Novartis Pharma AG, Basel, Switzerland

[2] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

[3] IQVIA, Paris, France

[4] Novartis Pharmaceut, E Hanover, NJ USA

[5] Hosp Civils Lyon, Hop Neurol, Serv Neurol, Sclerose Plaques Pathol Myeline & Neuroinflammat, Lyon, France

[6] Monash Univ, MS & Neuroimmunol Unit, Cent Clin Sch, Alfred Ctr, Clayton, Vic, Australia

[7] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

[8] Ninewells Hosp & Med Sch, Dundee, Scotland

[9] Ruhr Univ, St Josef Hosp, Dept Neurol, Bochum, Germany

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1118

引用

页码：646 / 646

页数：1

共 50 条

[41] Adherence to treatment with fingolimod after switching from interferon beta among patients with multiple sclerosis
Golan, D.
Levy, S.
Miller, A.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 708 - 708
[42] PAROXYSMAL ATRIAL FIBRILLATION AFTER INITIATION OF FINGOLIMOD FOR MULTIPLE SCLEROSIS TREATMENT
Rolf, Linda
Muris, Anne-Hilde
Damoiseaux, Jan
van Daele, Marc
Hupperts, Raymond
NEUROLOGY, 2014, 82 (11) : 1008 - 1009
[43] Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
Petsas, Nikolaos
De Giglio, Laura
Gonzalez-Quintanilla, Vicente
Giuliani, Manuela
De Angelis, Floriana
Tona, Francesca
Carmellini, Maurizio
Mainero, Caterina
Pozzilli, Carlo
Pantano, Patrizia
FRONTIERS IN NEUROLOGY, 2019, 10
[44] Administering Fingolimod to Patients with Multiple Sclerosis
Okamoto, T.
Lin, Y.
Araki, M.
Sato, W.
Murata, M.
Yamamura, T.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 929 - 929
[45] Fingolimod safety in patients with multiple sclerosis
Carrascosa Piquer, Olga
Antonino de la Camara, Gonzalo
Aparicio, Celia
de la Vega, Ivan
Mejia, Luisa
Garcia del Busto, Natalia
Quintana, Belen
Sanchez, Agustin
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 219 - 219
[46] Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
David, Olivier J.
Berwick, Amy
Pezous, Nicole
Lang, Michael
Tiel-Wilck, Klaus
Ziemssen, Tjalf
Li, Peng
Hara, Hisanori
Schmouder, Robert
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 217 - 221
[47] Pregnancy and foetal outcomes after glatiramer acetate exposure in patients with multiple sclerosis
Giannini, M.
Portaccio, E.
Ghezzi, A.
Hakiki, B.
Pasto, L.
Razzolini, L.
De Giglio, L.
Pozzilli, C.
Paolicelli, D.
Trojano, M.
Marrosu, M. G.
Patti, F.
La Mantia, L.
Mancardi, G.
Solaro, C.
Totaro, R.
Tola, M. R.
Di Tommaso, V.
Lugaresi, A.
Moiola, L.
Martinelli, V.
Comi, G.
Amato, M. P.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S303 - S304
[48] Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod
Czlonkowska, Anna
Smolinski, Lukasz
Litwin, Tomasz
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2017, 51 (02) : 156 - 162
[49] Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
Assunta Bianco
Matteo Lucchini
Rocco Totaro
Roberta Fantozzi
Giovanna De Luca
Sonia Di Lemme
Giorgia Presicce
Luana Evangelista
Valeria Di Tommaso
Roberta Pastorino
Chiara De Fino
Valeria De Arcangelis
Diego Centonze
Massimiliano Mirabella
Neurotherapeutics, 2021, 18 : 2598 - 2607
[50] Neurological adverse events after fingolimod administration in patients with multiple sclerosis
Mukai, T.
Okamoto, T.
Taminato, T.
Lin, Y.
Araki, M.
Sato, W.
Yamamura, T.
Takahashi, Y.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 788 - 788

← 1 2 3 4 5 →